Related references
Note: Only part of the references are listed.Absolute Measurement of Species Differences in Sodium Taurocholate Cotransporting Polypeptide (NTCP/Ntcp) and its Modulation in Cultured Hepatocytes
Xi Qiu et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Mechanistic Modeling to Predict the Transporter- and Enzyme-Mediated Drug-Drug Interactions of Repaglinide
Manthena V. S. Varma et al.
PHARMACEUTICAL RESEARCH (2013)
Impact of drug transporter pharmacogenomics on pharmacokinetic and pharmacodynamic variability - considerations for drug development
Yurong Lai et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2012)
Characterization of Organic Anion Transporting Polypeptide (OATP) Expression and Its Functional Contribution to the Uptake of Substrates in Human Hepatocytes
Emi Kimoto et al.
MOLECULAR PHARMACEUTICS (2012)
Physiologically Based Modeling of Pravastatin Transporter-Mediated Hepatobiliary Disposition and Drug-Drug Interactions
Manthena V. S. Varma et al.
PHARMACEUTICAL RESEARCH (2012)
In Vitro Evaluation of Hepatic Transporter-Mediated Clinical Drug-Drug Interactions: Hepatocyte Model Optimization and Retrospective Investigation
Yi-an Bi et al.
DRUG METABOLISM AND DISPOSITION (2012)
Mechanistic Pharmacokinetic Modeling for the Prediction of Transporter-Mediated Disposition in Humans from Sandwich Culture Human Hepatocyte Data
Hannah M. Jones et al.
DRUG METABOLISM AND DISPOSITION (2012)
Kinetic Characterization of Rat Hepatic Uptake of 16 Actively Transported Drugs
Yoshiyuki Yabe et al.
DRUG METABOLISM AND DISPOSITION (2011)
Interaction of fluvastatin with the liver-specific Na+-dependent taurocholate cotransporting polypeptide (NTCP)
Rick Greupink et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
Differential effect of genetic variants of Na+-taurocholate co-transporting polypeptide (NTCP) and organic anion-transporting polypeptide 1B1 (OATP1B1) on the uptake of HMG-CoA reductase inhibitors
Min-Koo Choi et al.
XENOBIOTICA (2011)
Transporter Pharmacogenetics and Statin Toxicity
M. Niemi
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Investigation of the Rate-Determining Process in the Hepatic Elimination of HMG-CoA Reductase Inhibitors in Rats and Humans
Takao Watanabe et al.
DRUG METABOLISM AND DISPOSITION (2010)
Study of the transport of thyroid hormone by transporters of the SLC10 family
W. Edward Visser et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Membrane transporters in drug development
Kathleen M. Giacomini et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Physiologically Based Pharmacokinetic Modeling to Predict Transporter-Mediated Clearance and Distribution of Pravastatin in Humans
Takao Watanabe et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Impact of Hepatic Uptake Transporters on Pharmacokinetics and Drug-Drug Interactions: Use of Assays and Models for Decision Making in the Pharmaceutical Industry
Mathew G. Soars et al.
MOLECULAR PHARMACEUTICS (2009)
Absolute quantification of multidrug resistance-associated protein 2 (MRP2/ABCC2) using liquid chromatography tandem mass spectrometry
Na Li et al.
ANALYTICAL BIOCHEMISTRY (2008)
Identification of interspecies difference in efflux transporters of hepatocytes from dog, rat, monkey and human
Meng Li et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Localization of P-gp (Abcb1) and Mrp2 (Abcc2) in freshly isolated rat hepatocytes
Daniel A. J. Bow et al.
DRUG METABOLISM AND DISPOSITION (2008)
In vitro-in vivo correlation of hepatobiliary drug clearance in humans
G. Ghibellini et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Drug and bile acid transporters in rosuvastatin hepatic uptake: Function, expression, and pharmacogenetics
Richard H. Ho et al.
GASTROENTEROLOGY (2006)
Transporters as a determinant of drug clearance and tissue distribution
Y Shitara et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Use of cryopreserved human hepatocytes in sandwich culture to measure hepatobiliary transport
Yi-an Bi et al.
DRUG METABOLISM AND DISPOSITION (2006)
Transporter-mediated influx and efflux mechanisms of pitavastatin, a new inhibitor of HMG-CoA reductase
H Fujino et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2005)
Ethnicity-dependent polymorphism in Na+-taurocholate cotransporting polypeptide (SLC10A1) reveals a domain critical for bile acid substrate recognition
RH Ho et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Rosuvastatin pharmacokinetics in heart transplant recipients administered an antirejection regimen including cyclosporine
SG Simonson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Enterohepatic bile salt transporters in normal physiology and liver disease
GA Kullak-Ublick et al.
GASTROENTEROLOGY (2004)
Share Paper
